Cross-linking as Treatment in Infectious Keratitis

Status Completed

Clinical Trial Summary

To compare between SCXL and ACXL for treatment of infectious keratitis

Clinical Trial Description

Standard epithelium-off CXL, 30 minutes soaking time with riboflavin, 30 minutes UVA corneal irradiation continuous mode (Group A). Accelerated CXL 11 minutes soaking time with riboflavin, 8 minutes UVA corneal irradiation pulsed mode (Group B). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04383431
Study type	Interventional
Source	Sohag University
Contact
Status	Completed
Phase	N/A
Start date	June 2, 2020
Completion date	January 15, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04030403` - Investigation of the Microbiome of the Cornea in Microbial Keratitis
Completed	`NCT04213313` - Association Between SNP of SP-D and Susceptibility and Prognosis of Infectious Keratitis
Recruiting	`NCT02570321` - Cross-linking for Corneal Ulcers Treatment Trial	Phase 4
Terminated	`NCT00912509` - Cross Linking for Treatment of Corneal Infection	N/A
Completed	`NCT01831206` - Collagen Cross-linking in Infectious Keratitis Trial	Phase 2
Recruiting	`NCT05888987` - Use of a New Method for the Microbiological Diagnosis of Severe Corneal Infection
Not yet recruiting	`NCT03801590` - Crosslinking in Infectious Keratitis	N/A
Recruiting	`NCT06364878` - Non-invasive Diagnostics of Microbial Keratitis
Completed	`NCT01739673` - Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis	N/A
Completed	`NCT02819232` - Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious Germs	N/A